https://www.selleckchem.com/pr....oducts/Metformin-hyd
BACKGROUND/PURPOSE Non-alcoholic fatty liver disease (NAFLD) patients are at increased risk of liver-related as well as cardiovascular mortality, including diabetes, coronary heart disease, and stroke, independently of traditional cardiovascular risk factors and metabolic syndrome. The aim of this study was to find out the predictive impact of hepatorenal index (HRI) in the detection of impaired glucose metabolism in asymptomatic NAFLD patients. METHODS B-mode ultrasound examinations were performed and ultras
Beğen
Yorum Yap
Paylaş
